Why is Saroja Pharma In falling/rising?

As of 23-Sep, Saroja Pharma Industries India Ltd's stock price is flat at 46.00, with no change (0.00%). The stock has underperformed in the short term, with a 1-week return of -2.23% and a 1-month return of -17.12%. Today's price summary indicates that the stock outperformed its sector by 0.35%, but it is currently above the 50-day, 100-day, and 200-day moving averages while being below the 5-day and 20-day moving averages. Additionally, there has been a significant decline in investor participation, as the delivery volume on 22 September fell by 37.5% compared to the 5-day average, which may indicate waning interest. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's movement.
In the broader market context, Saroja Pharma's recent performance contrasts sharply with the benchmark Sensex, which has shown a slight decline of only -0.28% over the past week. While the stock has faced a substantial year-to-date decline of -23.33%, the Sensex has gained 6.45% during the same period, highlighting a significant divergence in performance. This suggests that Saroja Pharma is struggling relative to the overall market, which may contribute to investor caution and the stock's current flat price movement.